Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Exagen Inc - SIC # 8082 - HOME HEALTH CARE SERVICES
Ticker
Exchange
SIC #
Website
Latest Ticker
XGN
Nasdaq
8082
https://exagen.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Exagen Inc
Analyst Estimates: Here's What Brokers Think Of Exagen Inc. (NASDAQ:XGN) After Its Annual Report
- Mar 21st, 2024 10:25 am
Exagen Full Year 2023 Earnings: Beats Expectations
- Mar 20th, 2024 10:16 am
Exagen Inc. (NASDAQ:XGN) Q4 2023 Earnings Call Transcript
- Mar 19th, 2024 1:37 pm
Q4 2023 Exagen Inc Earnings Call
- Mar 19th, 2024 5:55 am
Exagen Inc. (XGN) Reports Q4 Loss, Tops Revenue Estimates
- Mar 18th, 2024 1:25 pm
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 Results
- Mar 18th, 2024 12:00 pm
Exagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
- Mar 8th, 2024 2:00 pm
Exagen to Announce Fourth Quarter 2023 and Full-Year Financial Results on March 18, 2024
- Mar 7th, 2024 9:05 pm
Despite Fast-paced Momentum, Exagen Inc. (XGN) Is Still a Bargain Stock
- Feb 6th, 2024 1:50 pm
Exagen Inc. to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
- Jan 30th, 2024 9:05 pm
Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms Guidance
- Jan 7th, 2024 5:00 pm
Exagen Inc. Reports Strong Third Quarter 2023 Results
- Nov 13th, 2023 9:05 pm
Exagen Inc. and Johns Hopkins University Announce License Agreement for Novel Patented Lupus Nephritis Biomarkers
- Nov 9th, 2023 9:05 pm
Exagen Inc. to Participate in the 2023 Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
- Nov 2nd, 2023 8:05 pm
Exagen to Announce Third Quarter 2023 Financial Results on November 13, 2023
- Oct 30th, 2023 8:05 pm
Exagen Announces Acceptance of Multiple Abstracts at ACR 2023 Annual Meeting
- Sep 28th, 2023 8:05 pm
Exagen Inc. to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
- Sep 12th, 2023 8:05 pm
Exagen Inc. (NASDAQ:XGN) Q2 2023 Earnings Call Transcript
- Aug 9th, 2023 2:47 pm
Q2 2023 Exagen Inc Earnings Call
- Aug 8th, 2023 8:13 am
Exagen Inc. (XGN) Reports Q2 Loss, Tops Revenue Estimates
- Aug 7th, 2023 1:15 pm
Scroll